Manufacturer
Janssen (Johnson & Johnson) NDC Codes
Finished products listed with the FDA under labeler names that contain “Janssen”.
Most-listed names
By number of FDA listings (strengths, forms and packages), not by sales.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Akeeganiraparib tosylate monohydrate and abiraterone acetate | Niraparib tosylate monohydrate 50 mg/1; Abiraterone acetate 500 mg/1 | Tablet, Film coatedOral | Janssen Biotech, Inc. | 57894-050 |
| Akeeganiraparib tosylate monohydrate and abiraterone acetate | Niraparib tosylate monohydrate 100 mg/1; Abiraterone acetate 500 mg/1 | Tablet, Film coatedOral | Janssen Biotech, Inc. | 57894-100 |
| Balversaerdafitinib | Erdafitinib 3 mg/1 | Tablet, Film coatedOral | Janssen Products LP | 59676-030 |
| Balversaerdafitinib | Erdafitinib 4 mg/1 | Tablet, Film coatedOral | Janssen Products LP | 59676-040 |
| Balversaerdafitinib | Erdafitinib 5 mg/1 | Tablet, Film coatedOral | Janssen Products LP | 59676-050 |
| Carvykticiltacabtagene autoleucel | Ciltacabtagene autoleucel 100000000 1/1 | Injection, SuspensionIntravenous | Janssen Biotech, Inc. | 57894-111 |
| Concertamethylphenidate hydrochloride | Methylphenidate hydrochloride 18 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-585 |
| Concertamethylphenidate hydrochloride | Methylphenidate hydrochloride 36 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-586 |
| Concertamethylphenidate hydrochloride | Methylphenidate hydrochloride 54 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-587 |
| Concertamethylphenidate hydrochloride | Methylphenidate hydrochloride 27 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-588 |
| Darzalexdaratumumab | Daratumumab 100 mg/5mL | Injection, Solution, ConcentrateIntravenous | Janssen Biotech, Inc. | 57894-502 |
| Darzalex Fasprodaratumumab and hyaluronidase-fihj (human recombinant) | Daratumumab 1800 mg/15mL; Hyaluronidase (Human recombinant) 30000 U/15mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-503 |
| Darzalex IVdaratumumab | Daratumumab 100 mg/5mL | Injection, Solution, ConcentrateIntravenous | Janssen Biotech, Inc. | 57894-505 |
| Edurantrilpivirine hydrochloride | Rilpivirine hydrochloride 25 mg/1 | Tablet, Film coatedOral | Janssen Products, LP | 59676-278 |
| Edurant Pedrilpivirine hydrochloride | Rilpivirine hydrochloride 2.5 mg/1 | Tablet, For suspensionOral | Janssen Products, LP | 59676-280 |
| Elmironpentosan polysulfate sodium | Pentosan polysulfate sodium 100 mg/1 | Capsule, Gelatin coatedOral | Janssen Pharmaceuticals, Inc. | 50458-098 |
| Erleadaapalutamide | Apalutamide 60 mg/1 | Tablet, Film coatedOral | Janssen Products, LP | 59676-600 |
| Erleadaapalutamide | Apalutamide 240 mg/1 | Tablet, Film coatedOral | Janssen Products, LP | 59676-604 |
| Icotydeicotrokinra | Icotrokinra 200 mg/1 | Tablet, Film coatedOral | Janssen Biotech, Inc. | 57894-201 |
| Imaavynipocalimab-aahu | Nipocalimab 185 mg/mL | Injection, Solution, ConcentrateIntravenous | Janssen Biotech, Inc. | 57894-800 |
| Imaavynipocalimab-aahu | Nipocalimab 185 mg/mL | Injection, Solution, ConcentrateIntravenous | Janssen Biotech, Inc. | 57894-801 |
| Infliximab | Infliximab 100 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | Janssen Biotech, Inc. | 57894-160 |
| Inlexzogemcitabine intravesical | Gemcitabine 225 mg/1 | SystemIntravesical | Janssen Biotech, Inc | 57894-225 |
| Intelenceetravirine | Etravirine 100 mg/1 | TabletOral | Janssen Products LP | 59676-570 |
| Intelenceetravirine | Etravirine 200 mg/1 | TabletOral | Janssen Products LP | 59676-571 |